Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Max A. Martinson, BSc
JCP
Original Research
T-CSCT for Depressed Chinese Americans
August 24, 2016
T-CSCT for Depressed Chinese Americans
Albert Yeung
,
Maurizio Fava
,
Lee Baer
, et al
JCP
Meta-Analysis
Monotherapy in Mood Disorders
May 25, 2016
Is one drug good enough? Read this review of 215 double-blind, randomized, placebo-controlled trials to discover which monotherapies have overall short-term efficacy in treating MDD and bipolar depression.
Maurizio Fava
,
George I. Papakostas
,
Nadia Iovieno
, et al
JCP
Original Research
A Double-Blind, Randomized Controlled Clinical Trial Comparing Eicosapentaenoic Acid Versus Docosahexaenoic Acid for Depression
September 16, 2014
David Mischoulon
,
Andrew A. Nierenberg
,
Mark Hyman Rapaport
, et al
